Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

被引:0
作者
Yun-Hsuan Lin
Tai-Lin Huang
Chih-Yen Chien
Hui-Chun Chen
Hsuan-Chih Hsu
Eng-Yen Huang
Chong-Jong Wang
Yu-Jie Huang
Yu-Ming Wang
Chun-Chieh Huang
Shang-Yu Chou
Kuan-Cho Liao
Fu-Min Fang
机构
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Radiation Oncology
[2] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Hematology and Oncology
[3] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Otolaryngology
来源
Radiation Oncology | / 13卷
关键词
Nasopharyngeal carcinoma; Simultaneous integrated boost intensity-modulated radiation therapy; Hematologic inflammatory marker; Epstein-Barr virus DNA; Gross tumor volume;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 197 条
[11]  
Garden AS(2012)Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma Head Neck 34 1769-7787
[12]  
Straube W(2015)Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients Oncol Lett 9 1458-45
[13]  
Glisson B(2016)Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio Head Neck 38 E1332-129
[14]  
Xia P(2015)The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients Tumor Biol 36 7775-299
[15]  
Lin S(2013)Increase platelet count is an indicator of metastasis in patients with nasopharyngeal carcinoma Tumor Biol 34 39-76
[16]  
Pan J(2016)Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: a pooled analysis of two randomized controlled trials Eur J Cancer 67 119-720
[17]  
Han L(2012)Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol 104 294-133
[18]  
Zhang X(2014)Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy J Cancer Res Clin Oncol 140 69-E1032
[19]  
Liao X(2006)Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 714-207
[20]  
Lu JJ(2011)Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy Clin Oncol 23 128-e852